The XTLB news vis-à-vis the HCV program is not a surprise; as far as I can tell, no one who is knowledgeable in the HCV arena thought XTLB was a serious player there.
This post from 2006 is worth reading (or rereading) in light of what has transpired: #msg-12350273. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.